Goldman Sachs BDC Inc
NYSE:GSBD
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
12.65
15.91
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Good morning. This is Dennis, and I will be your conference facilitator today. I would like to welcome everyone to the Goldman Sachs BDC, Inc. Third Quarter 2020 Earnings Conference Call. Please note that all participants will be in listen-only mode until the end of the call when we will open up the line for questions.
Before we begin today's call, I would like to remind our listeners that today's remarks may include forward-looking statements. These statements represent the Company's belief regarding future events that by their nature are uncertain and outside of the Company's control. The Company's actual results and financial condition may differ, possibly materially, from what is indicated in those forward-looking statements as a result of a number of factors, including those described from time-to-time in the Company's SEC filings.
This audiocast is copyrighted material of Goldman Sachs BDC, Inc. and may not be duplicated, reproduced or rebroadcast without our consent.
Yesterday, after the market closed, the Company issued an earnings press release and posted a supplemental earnings presentation, both of which can be found on the homepage of our website at www.goldmansachsbdc.com under the Investor Resources section. These documents should be reviewed in conjunction with the Company's Form 10-Q filed yesterday with the SEC. This conference call is being recorded today, Friday, November 06, 2020, for replay purposes.
I'll now turn the call over to Brendan McGovern, Chief Executive Officer of Goldman Sachs BDC.
Thank you, Dennis. Good morning, everyone, and thank you for joining us for our third quarter earnings conference call. I'm joined on the call today by Jon Yoder, our Chief Operating Officer; and Jonathan Lamm, our Chief Financial Officer.
I'll begin the call by providing an overview of our third quarter results, including commentary on performance of our portfolio, and how we've navigated the economic uncertainty resulting from the COVID health crisis.
I'll also provide a recap of our recently completed merger with our previously affiliated business development company, Goldman Sachs Middle Market Lending Corp, which we refer to as MMLC. Jon Yoder will then discuss our portfolio activity in more detail before turning the call over to Jonathan Lamm to walk through our financial result. Finally, I'll conclude with some closing remarks before we open line for Q&A.
So with that, let's get to our third quarter results. Q3 net investment income per share was $0.45 on after tax net investment income of $18.2 million. Our GAAP earnings per share was $0.80, which reflected both the solid net investment income generated during the quarter, as well as net gains in our investment portfolio. The net gains reflected continued improvement in underlying portfolio company performance, coupled with a tightening of market spreads.
Net asset value per share increased to $15.49 per share as of September 30, an improvement of 2.3% from the end of the second quarter. As we announced after the market closed yesterday, our board declared a $0.45 per share dividend payable to shareholders of record as of December 31, 2020. This equates to an annualized dividend yield of 11.6% based on net asset value per share at the end of Q3.
Furthermore, our board declared special dividends aggregating to $0.15 per share, which will be payable in three $0.05 per share installments to shareholders of record on each of February 15, 2021, May 14, 2021 and August 16, 2021. We call it these special dividends were first approved last December when the initial merger with MMLC was announced.
Next, I'd like to take a moment to reflect on the overall state of the portfolio. As all of you are aware, it has now been over seven months since the beginning of the COVID-19 health crisis, which caused unprecedented social and economic disruption across the globe as government mandated lockdowns put tremendous stress and strain on businesses.
Against this extraordinary backdrop, we are extremely pleased with the performance and resilience of our investment portfolio. We want to share some further insights and observations that evidence the strength of the portfolio.
First, revenue at our portfolio companies increased by over 2% year-over-year based on the most recently available data despite the broad economic upheaval and broader contraction of economic activity. We attribute this solid performance to our focus on high quality businesses in durable and dynamic sectors of the economy, such as technology, business services in certain areas of healthcare that have non-discretionary demand drivers, coupled with strong management performance at our portfolio companies.
We've observed that healthy companies with forward-looking owners and management teams have capitalized on long-term expansion opportunities in this environment, primarily through M&A, which has further solidified leadership positions.
Net debt-to-EBITDA and our portfolio companies ticked up mostly quarter-over-quarter, but at 5.7 times still remains consistent with historical levels. Furthermore, weighted average interest coverage, a measure of cash flow coverage of debt service remains very healthy at 2.6 times.
We know that investors are keenly focused on loan amendment activity as an indicator of any portfolio stress. We did observe that loan amendment activity was elevated in Q3, compared to historical levels. That said, however, the majority of amendments were granted the companies that are performing well for seeking technical relief in many cases to pursue the accretive M&A transactions as described earlier.
This dynamic has given rise to growth in our pipeline of attractive investment opportunities, which we are well positioned to pursue. In those instances, where companies are seeking covenant lease to manage the business impact from the health crisis, we have generally been successful in negotiating for junior equity capital to commence the businesses to support both liquidity and debt service.
In Q3, seven of our portfolio companies received commitments of new junior capital evidencing the confidence that business owners have in the enterprise value and future prospects of these businesses, as well as the safety and stability of the more senior portion of the capital structures where we invest. Presently, among the 110 companies in our portfolio, just one company is out of compliance with covenants.
In addition, we continue to observe their portfolio companies have the wherewithal to remain current on their cash obligations to us. And as a result, payment-in-kind or PIK income represents just 5.3% of total income during the quarter.
We believe the demonstrated ability for our portfolio companies to meet their interest obligations and cash is a testament to their underlying health and durability and bodes well for credit performance. During the quarter, no new investments were placed on nonaccrual, and total non-accruals were de-minimis at 0.1% of fair value, and 0.9% at cost at quarter end.
Next, I'm delighted to announce that on October 12, 2020 GSBD completed its previously announced merger with MMLC. We believe the transactions delivered significant benefits to all stakeholders.
For example, the transaction increased GSBD’s portfolio yield at cost, while at the same time reducing the percentage of non-accrual assets. With $3.5 billion of assets, the company has significant scale, which we believe delivers benefits to all stakeholders, including enhanced access to diversified sources of funding to further strengthen our balance sheet position.
To that end, perhaps the greatest benefit of the merger was a substantial deleveraging that occurred. As of the closing date of transaction GSBD’s net debt to equity ratio was just 0.93 times down from 1.29 times at the end of the third quarter. As a result of this deleveraging, the company is now well positioned to patiently deploy incremental capital and increase net investment income in the current environment.
Finally in connection with the completion of the merger, our Board of Directors has reauthorized and amended the company's 10b5-1 plan. The amended plan increases the buyback authorization to $75 million from $25 million previously, subject to certain conditions.
With that, let me turn it over to Jon Yoder.
Great, thanks Brendan.
So to pick up on some of the comments he made, we are certainly pleased with the stability and resilience demonstrated by our portfolio under adverse economic conditions over the past several months. In part, this strong performance can be attributed to a notable and deliberate shift in our asset composition towards more senior first lien loans over the past several years.
To recap our portfolio statistics at quarter end, total investments in our portfolio were $1.431.2 million at fair value, which was comprised of 93.2% in senior secured loans, including 75.5% in first lien, 2.4% and first lien last-out unitranche and 15.3% in second lien debt as well as 0.5% in unsecured debt, and 6.3% in preferred common stock and warrants. We also had just under $60 million of unfunded commitments as of September 30, bringing total investments and commitments to $1.490.4 million.
As of quarter end, the company had 110 portfolio companies operating across 38 different industries. The weighted average yield on our investment portfolio at cost at the end of the third quarter was 7.7% as compared to 7.5% at the end of the second quarter. The weighted average yield of our total debt and income producing investments at cost remained at 8.3% at the end of the quarter.
During the quarter, we made five new investment commitments, four of which were to new portfolio companies and one of which was to an existing portfolio company totaling $11.6 million. In addition, we received $24.7 million in repayments, which was driven primarily by the full repayment of investments in two portfolio companies. Overall, both sales and repayment activity was relatively muted this quarter.
As previously discussed, new asset origination was constrained during the quarter as we were operating at the high end of our target leverage ratio going into the merger with MMLC. As we look forward, we see significant incremental operating flexibility afforded by the deleveraging that resulted from that merger transaction. And as Brendan mentioned, we expect to be patient and thoughtful going forward as we deploy new capital into new investments.
Similarly, while repayment activity slowed significantly during the depths of the crisis. We do anticipate an increase in repayments consistent with the general uptick of transaction activity that we've experienced in private markets in recent months. Already in the fourth quarter, we've received full repayments of two portfolio companies, and a third portfolio company called GK Holdings, has agreed to merge with one of its competitors in conjunction with the sale of the combined company to SPAC.
GK Holdings had been an underperforming asset and as part of this SPAC transaction, we expect to receive a nearly full recovery of our first lien claim and the recovery on our second lien claim we expect to be significantly in excess of our mark as of the third quarter. As a result, we marked up the investment value prior to the closing of our merger on October 9. And we expect this transaction to close in early Q1 of 2021.
I will now turn the call over to Jonathan to walk through our financial results.
Thanks Jon.
We ended the third quarter of 2020 with total portfolio investments of fair value of $1.43 billion outstanding debt of $920 million and net assets of $626 million. Our net investment income per share was $0.45, which was unchanged from the prior quarter. Earnings per share were $0.80 as compared to $0.86 in the prior quarter. We ended the third quarter with a net debt to equity ratio of 1.29 times versus 1.33 times at the end of Q2.
Importantly as Brendan mentioned subsequent to the closing of the merger, the net debt to equity ratio came down to 0.93 times, thus providing the company with incremental capacity to deploy capital into new investment opportunities. During the crisis, the company maintained a significant amount of cash and cash equivalents directly on the balance sheet, as evidenced by the large difference between our gross and net debt to equity ratios.
Subsequent to the closing of the merger is the significant portion of that cash to pay down our secured revolving credit facility. In addition, pro forma for the completion of the merger at the end of Q3, the company had approximately $690 million of liquidity. I would also add that as of Q3, 2020, our unsecured debt percentage was 56%. But pro forma for the merger it is approximately 30% due to the high percentage of secured financing reported over from MMLC.
I would reiterate comments made on previous calls, that we are keenly focused on ensuring a healthy balance of unsecured debt in our capital stack, as it provides the company with significant financial flexibility, especially as evidenced on our own balance sheet during the crisis.
Turning to the income statement, our total investment income for the third quarter was $31.5 million, which was up from $30.6 million last quarter. The increase was primarily driven by an increase in prepayment related income and amendment fees. Net expenses were $12.9 million for the quarter as compared to $12 million in the prior quarter. Net expenses were up quarter-over-quarter primarily driven by the lower management fee waiver in Q3.
NAV was $15.49 per share up 2.3% from the prior quarter driven by net gains in our investment portfolio as a result of continued improvement in portfolio company performance as well as from further tightening of credit spreads. The company had $46.6 million in taxable accumulated undistributed net investment income at quarter end, resulting from net investment income that has exceeded our dividend historically.
Pro forma for the completion of the merger at the end of Q3, this equates to $0.46 per share. As discussed on prior calls, we believe that the cost of spilling over this income in the form of excise tax is a small price to pay relative to the much higher cost of issuing new equity.
With that, I will turn it back to Brendan.
Thanks Jonathan.
In closing, we are pleased with the performance of the company under these challenging operating conditions. During the quarter asset values continue to improve, non-accrual investments remained low. And we deleveraged the company's balance sheet which gives us great flexibility to navigate the current environment.
As a result, we believe the company is on a strong footing to continue to deliver track results for all our stakeholders. As always, we thank you for the privilege of managing our capital. And please don't hesitate to reach out if you have any questions.
With that Dennis will turn it back to you, open lines for questions.
[Operator Instructions] And your first question is from the line of Finian O'Shea with Wells Fargo Securities. Please go ahead.
Thanks for having me on. First is, Brendan can you remind us on the special dividends. Were those related to - those related to the waivers or just spillover in general or something else?
Yes Fin, good to hear from you. Yes, you'll recall when we initially announced the merger, back in December of last year we put in place the fee waiver. The thought we had that, since we're putting in this place the fee waiver there's incremental earnings, that would nerve that, it would be better to actually put that back into shareholder hands directly in the form of these specials. So back in December, we announced this 15% aggregate dividend.
And so that's the background there. This is something we've talked about going back since December. So no broader change in our dividend policy or chair, but we did think in connection with the merger and given us fee waivers better to put it back - cash back into shareholders hands.
And then just on GK. So obviously a good outcome for [indiscernible] I think that was at least on partial nonaccrual. Do you have like a restore amount of income next quarter, any color there? And then I suppose just on the mark, you had that marked down to I think 70 or so, or below this for sort of context like, did they improve - like recently get out of any duress or was any color on - go ahead.
I'll give you a little bit of background here on the goings on with GK. So yes, this is a business that does IT educational training, tax and services and had been in the process so it frankly a lot of it in classroom, but some of it online as well. And so had been under performance for quite some time and marks coming into at the end of Q2, we have a position in both the first and the second lien, the first lien I think we had marked somewhere around $0.50 on the dollar context when $0.52.
And the second was on nonaccrual, we had that marked lower around $0.25. And so what's happened in the context of COVID, the company has made some strides in moving their offerings to the online domain. But that's been a process there. But the real value proposition here was merging with one of their big competitors, and the back capital coming into effectuate that merger here.
And so on the combined basis and thinking of the synergies that nurses the company, the value that was offered to the - in this case to the debt holders of GK was effectively getting a full recovery on the first lien and a significant recovery back to the second lien.
And so we've in the context of that announcement, which was after September 30, but before the October 9, closing with the merger, post the quarter, we did mark up those positions in conjunction with that merger, that deal will close in the first quarter of next year, so that the character of our investment will be a cash take back as well as some take back paper, which will be performing that.
So very, very good outcome. And I think really indicative of - I would say one year conservatism on thinking through marks, and also just the value creation opportunities in an environment here where there is a lot of capital, looking for good opportunities, and so, yes, very good to be the beneficiary of that.
And then just one - I'm just doing really quick math here. I could be wrong. I think it's something like $6 million. And that helps and that brings your NAV up around $0.10 even after the closing cost. Yes, is there anything else going on or it?
Yes, so let me take you through a little bit of the bridge, Jonathan Lamm can chime in as well if I get something wrong here. But again, going back to the timing of the merger, we closed the merger on was October 12. And if you think about that process there in a NAV for NAV deal, what we did was a full breakdown of the NAVs of both GSBD and MMLC at the time that merger which was effectively October 09, the Friday before that weekend.
And so, what we did was look across the portfolio, look for any incremental news, the GK news was obviously significant, which engendered that markup, but in addition in both GSBDs and MMLCs NAV, we included the income that had been generated in that sub period into the NAV is of course that will end up getting distributed in dividends. But when you look at that at the ending 1557 NAV as of October 09 that we just described, a lot of that is the GK Holdings and part of that is the that sub period of income.
[Operator Instructions] Your next question is from the line of a Robert Dodd with Raymond James. Please go ahead.
Congratulations on closing the merger. Brend if I can go back to your comments on loan amendments? I mean, most of them it sounds like we're technical to your point. So they can maybe go to add-on acquisitions, but there was some that were not. Can you give us any of those that weren't - were those concentrated - I don’t want to say concentrated if they weren't? How many of those were in kind of those, there is more legacy like a better term, more difficult positions at GSBD versus were any of them in the more traditional assets that also overlap with MMLC i.e. were they in positions that now have obviously shrunk as a piece of the portfolio? Can you give us any color??
Good question. So I'll just reiterate some of the comments I made up front. So like I said, loan amendment activity was elevated, the majority of that, like I said, was really companies going on offence looking for incremental is looking for flexibility to pursue those acquisition opportunities and incur debt. And like and which is, we think a positive event. And so I don't want to leave you with the impression that there was a lot of those other companies that were seeking incremental capital. And I think, I noted that, in those cases where we were offering flexibility, really pleased that it was in partnership with the sponsors and the owners who were willing to provide Junior capital. And that's consideration forgiving flexibility.
And it really speaks to the evidence of the value there. As I sort of catalogue in my head. Those names, I don't think there's any significance lack of overlap, I think those are those are names that are really across both of those vehicles, as we've been co-investing those vehicles for the past many years.
And then just on the other one, I mean, obviously now leverage is down, you've got capital, you've got liquidity.
Right.
You know, what are you seeing out there not just in opportunities, obviously M&A activity et cetera, private equity activity is up, will lead to more repayments as well, potentially, but in terms of terms that you're seeing that, in terms of the type of industries obviously, you want the more tech defensive, you know, the kind of businesses that produce that revenue in a recession.
So are you seeing the light kind of industries and what are the terms that are available in the market right now?
On the industry that absolutely, and I think, as we look at the at the perspective environment, we're going to continue to focus on those industries, where having had the ability to observe how they performed in a very stressful economic environment and seeing the resilience.
We're very pleased with the sectors where we've been active in the sectors that we've avoided, you know, think of oil and gas, retail and other troubled areas, we've done a nice job of missing those. So we will definitely continue to focus on those areas of technology and business services and healthcare that you definitely feel more resilience.
And yes, the good news is, by virtue of having been quite active there over many years, we feel like we've got excellent access to those opportunities, both on new deals, as well as those add-ons that I talked about in the context of [indiscernible] on terms you looked at, yes, it's a dynamic environment for sure. We've all observed what's going on in the broader public markets, and there's typically a lag with private markets.
But things have definitely tightened. I wouldn't say we're back at pre-COVID levels by any stretch of the imagination, but relative to call it the summertime or September, as we've been getting more active, certainly new opportunities have tightens, but we think there are still opportunities to do transactions that are in the part of the capital structure that we prefer that are in the names of industries that we prefer, that can be accretive to the overall portfolio yield. And that's where our focus is.
And just on - I mean, obviously now in many cases the opportunities that do come up, you have the data of how they performed to your point, you know how these companies right performed during COVID. Does that mean you're going to have more appetite for more - doing some Junior deals and by Junior I mean like secondly matters, but what would concern?
Yes, no, we haven't changed our orientation. We've not gotten more active in the capital, I think you can certainly envision environment. And look, we've talked about this since the early days of the small business credit availability act. Markets are dynamic, there are certainly can be points in time when the supply meaning that the lenders that are willing to offer that generic capital diminishes relative to the demand, which could give rise to outsize opportunities.
And so we're always mindful of that, I don't think we're quite there yet in terms of seeing that flipped to being quite obvious. But it's something that we will certainly consider if and when those opportunities do arise. And as you know, Robert, there is a relationship between the ultimate balance sheet leverage and your assets mix as well.
And so as we sit here today, you know, I think our focus will continue to be on the margin on first lien deals, as we're and we're using the incremental debt capacity we have in the company to finance those assets.
Could that change? Absolutely. I don't think I'm sitting here today, signaling any change in that profile, but we're certainly eyes wide open to the possibilities.
[Operator Instructions] And at this time, there appear to be no further questions. Please continue with any closing remarks.
Great. Thanks, Dennis. And thank you all of you of course for joining us for the earnings conference call today. Obviously, a lot going on in the world would be always eager and happy to answer any questions and feel free to reach out directly and we look forward to chatting soon. Have a great weekend.
Ladies and gentlemen, this does conclude the Goldman Sachs BDC, Inc. third quarter 2020 earnings conference call. Thank you for your participation. You may now disconnect.